Benfluorex hydrochloride 是一种肝核因子 4α (HNF4α) 激活剂。

Benfluorex is an anorectic and hypolipidemic agent that is structurally related to fenfluramine. It was patented and manufactured by a French pharmaceutical company Servier. On 18 December 2009, the European Medicines Agency (EMEA) recommended the withdrawal of all medicines containing benfluorex in the European Union, because their risks, particularly the risk of heart valve disease (fenfluramine-like cardiovascular side-effects), are greater than their benefits.

23642-66-2

C19H21ClF3NO2

387.83

Mediaxal;Lipophoral;Balans;盐酸苯氟雷司;Benfluorex hydrochloride

DMSO:10 mM
Powder: -20°C for 3 years
In solvent: -80°C for 2 years